Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmaceutical policy and the lay public.

Janine M Traulsen1, Anna Birna Almarsdóttir

  • 1Department of Social Pharmacy, The Danish University of Pharmaceutical Sciences, Copenhagen, Denmark. jam@dfuni.dk

Pharmacy World & Science : PWS
|October 18, 2005
PubMed
Summary

Patient involvement in pharmaceutical policy is limited due to various factors, including differing perspectives and the influence of special interest groups. Research is recommended to better understand and incorporate diverse patient needs into policy development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring Medication Adherence in Heart Failure From a Patient Perspective: A Qualitative Study.

Circulation. Heart failure·2026
Same author

An ideological playground? Changes in community pharmacy ownership - a case study from four Nordic and Baltic countries.

Journal of pharmaceutical policy and practice·2025
Same author

Validation of the Danish translation of the vaccination attitudes examination (VAX) scale.

Vaccine·2025
Same author

Factors Influencing Medication Adherence in Heart Failure Patients-A Survey Among Cardiac Healthcare Providers.

Clinical pharmacology and therapeutics·2024
Same author

Impact of Regulatory Risk Communication on Thrombosis With Thrombocytopenia Syndrome for COVID-19 Adenovirus Vector Vaccines on European Healthcare Professionals.

Pharmacoepidemiology and drug safety·2024
Same author

Challenges in the Implementation of EU Risk Minimisation Measures for Medicinal Products in Clinical Practice Guidelines: Mixed Methods Multi-Case Study.

Drug safety·2024

Area of Science:

  • Health Policy
  • Pharmaceutical Policy
  • Public Health

Background:

  • Health policy documents emphasize patient empowerment and involvement.
  • The link between pharmaceutical policy and the public is indirect, mediated by various actors.
  • Currently, only a few organized groups, often industry-supported, influence policymaking.

Purpose of the Study:

  • To analyze the challenges and complexities of involving the lay public in health and pharmaceutical policymaking.
  • To identify barriers to effective citizen engagement in policy development.
  • To recommend research directions for better understanding lay perspectives in pharmaceutical policy.

Main Methods:

  • The study reviews existing literature and policy documents.
  • It analyzes the dynamics between policymakers, patients, healthcare professionals, and other stakeholders.

Related Experiment Videos

  • Qualitative analysis of factors hindering public involvement.

    • Main Results:

    • Lack of consensus on the meaning of public involvement.
    • Predominance of special interest groups and narrow agendas.
    • Discrepancies between patient and professional views on medicine.
    • Challenges in identifying and prioritizing diverse lay needs.

    Conclusions:

    • Citizen involvement in pharmaceutical policy is nascent but developing.
    • Addressing diverse lay needs requires further research and structured engagement.
    • Overcoming barriers to lay participation is crucial for equitable health policy.